Tendyne™ TENDV-SP-41S
Tendyne™ TENDV-SP-41S is a Class III device made by St. Jude Medical, Inc., approved under FDA PMA P240042 on 23 May 2025 and listed in FDA GUDID since 29 May 2025 (UDI-DI 05415067032553), active as of 23 Oct 2026.
Active
PMA
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number05415067032553 | Date29 May 2025 | StatusListed |
| United States | FDA PMAAPPR | NumberP240042 | Date23 May 2025 | StatusActive |
Official records
- AccessGUDID record 05415067032553
- FDA PMA database P240042
Across registries
- FDA PMA P240042 decided 23 May 2025 Active
- FDA GUDID UDI-DI 05415067032553 listed 29 May 2025 Listed
Timeline
- Approved FDA PMA P240042
- Listed FDA GUDID 05415067032553
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Trade name
- Tendyne™
- Generic name
- Mitral transcatheter heart valve bioprosthesis
- Model / Ref / Catalog
- TENDV-SP-41S
- Primary DI / UDI-DI
- 05415067032553
- PMA number
- FDA product code
- NPU
- GMDN term
- Mitral transcatheter heart valve bioprosthesis
- Device class
- Class III
- GUDID distribution status
- In Commercial Distribution
- MRI safety
- MR Conditional